Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2008 Oct 19;74(1):38–46. doi: 10.1016/j.ijrobp.2008.06.1943

Table 3.

Literature summary: CN involvement of patients with HNCSCC and CPNI

Series Total number of patients Involved nerves V+VII involvement
Cottel et. al.24 14 V1-6
V2-4
Auriculotemporal nerve-3
VII-1
Greater occipital nerve-1
III, IV and VI-1* 		2†
Garcia-Serra et. al.4 76 VII-23+7*
V1-10
V2-34+4*
V3-11+10*
II-1*
III-4*
IV-3*
VI-7* 		At presentation-5%
Secondarily-20%†
Catalano et. al.25 7 VII-7
V3-3
V2-2
III, IV, VI-1		 4 (57%)
McNab et. al.8††§ 21 VII-14
V-20
CN III, IV or VI-14		 14 (67%)
Clouston et. al.10†† 5 V-5
VII-5
III, IV or VI-5		 5 (100%)
Morris et. al.11 26 VII-15
V-17
Greater auricular nerve-4
III-2		 Not reported
Ballantyne et. al.14 26 V-19
VII-14
Greater auricular nerve-3
III, IV, VI VIII-2* 		11 (42%)
Bowyer et. al.6 17 V1-12
V2-4
III, IV and VI-10
VII-5
II-4		 4 (24%)
Valenzuela et. al.17††§ 8 V1-7
V2-3
VII-5
CN III, IV or VI-4* 		4 (50%)
Current series 12 V-11
VII-11
CN III, IV and VI-3		 10 (92%)
*

Secondary involvement

†

Overall incidence of involvement of more than one nerve

††

Periorbital tumors

§

The authors report symptoms rather than the involved nerves